The Mitochondria in Diabetic Heart Failure: From Pathogenesis to Therapeutic Promise
- 10 June 2015
- journal article
- review article
- Published by Mary Ann Liebert Inc in Antioxidants and Redox Signaling
- Vol. 22 (17), 1515-1526
- https://doi.org/10.1089/ars.2015.6294
Abstract
Significance: Diabetes is an important risk factor for the development of heart failure (HF). Given the increasing prevalence of diabetes in the population, strategies are needed to reduce the burden of HF in these patients. Recent Advances: Diabetes is associated with several pathologic findings in the heart including dysregulated metabolism, lipid accumulation, oxidative stress, and inflammation. Emerging evidence suggests that mitochondrial dysfunction may be a central mediator of these pathologic responses. The development of therapeutic approaches targeting mitochondrial biology holds promise for the management of HF in diabetic patients. Critical Issues: Despite significant data implicating mitochondrial pathology in diabetic cardiomyopathy, the optimal pharmacologic approach to improve mitochondrial function remains undefined. Future Directions: Detailed mechanistic studies coupled with more robust clinical phenotyping will be necessary to develop novel approaches to improve cardiac function in diabetes. Moreover, understanding the interplay between diabetes and other cardiac stressors (hypertension, ischemia, and valvular disease) will be of the utmost importance for clinical translation of scientific discoveries made in this field. Antioxid. Redox Signal. 22, 1515–1526.Keywords
This publication has 113 references indexed in Scilit:
- Lipid-Induced Mitochondrial Stress and Insulin Action in MuscleCell Metabolism, 2012
- Muscle-Specific Deletion of Carnitine Acetyltransferase Compromises Glucose Tolerance and Metabolic FlexibilityCell Metabolism, 2012
- Oxidized Mitochondrial DNA Activates the NLRP3 Inflammasome during ApoptosisImmunity, 2012
- Oxidative stress and diabetes: What can we learn about insulin resistance from antioxidant mutant mouse models?Free Radical Biology & Medicine, 2012
- The transcriptional coactivators, PGC-1α and β, cooperate to maintain cardiac mitochondrial function during the early stages of insulin resistanceJournal of Molecular and Cellular Cardiology, 2011
- Antioxidant treatment protects diabetic rats from cardiac dysfunction by preserving contractile protein targets of oxidative stressThe Journal of Nutritional Biochemistry, 2010
- Thioredoxin glycation: A novel posttranslational modification that inhibits its antioxidant and organ protective actionsFree Radical Biology & Medicine, 2010
- Comparison of Patients With Heart Failure and Preserved Left Ventricular Ejection Fraction Among Those With Versus Without Diabetes MellitusThe American Journal of Cardiology, 2010
- Substrate-Specific Derangements in Mitochondrial Metabolism and Redox Balance in the Atrium of the Type 2 Diabetic Human HeartJournal of the American College of Cardiology, 2009
- Resveratrol alleviates cardiac dysfunction in streptozotocin-induced diabetes: Role of nitric oxide, thioredoxin, and heme oxygenaseFree Radical Biology & Medicine, 2007